GlobeImmune   Report issue

For profit Phase 2
Founded: Louisville CO United States (1995)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2005
NCT00124215
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now